Zinc in PDB 6cvr: Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex
Enzymatic activity of Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex
All present enzymatic activity of Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex:
3.1.11.7;
3.1.12.2;
Protein crystallography data
The structure of Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex, PDB code: 6cvr
was solved by
M.J.Schellenberg,
P.S.Tumbale,
R.S.Williams,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
38.39 /
1.88
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
40.616,
116.056,
117.563,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.6 /
19
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex
(pdb code 6cvr). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex, PDB code: 6cvr:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 6cvr
Go back to
Zinc Binding Sites List in 6cvr
Zinc binding site 1 out
of 2 in the Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn402
b:34.9
occ:1.00
|
NE2
|
A:HIS335
|
2.1
|
38.8
|
1.0
|
NE2
|
A:HIS339
|
2.1
|
45.0
|
1.0
|
SG
|
A:CYS322
|
2.3
|
45.5
|
1.0
|
SG
|
A:CYS319
|
2.4
|
38.2
|
1.0
|
CD2
|
A:HIS335
|
2.9
|
36.3
|
1.0
|
HD2
|
A:HIS335
|
3.0
|
43.5
|
1.0
|
CE1
|
A:HIS339
|
3.0
|
46.7
|
1.0
|
CD2
|
A:HIS339
|
3.0
|
44.2
|
1.0
|
HB3
|
A:CYS322
|
3.0
|
57.1
|
1.0
|
CE1
|
A:HIS335
|
3.1
|
40.1
|
1.0
|
HB3
|
A:CYS319
|
3.1
|
44.4
|
1.0
|
CB
|
A:CYS319
|
3.2
|
37.0
|
1.0
|
H
|
A:CYS322
|
3.2
|
52.5
|
1.0
|
HE1
|
A:HIS339
|
3.2
|
56.0
|
1.0
|
HD2
|
A:HIS339
|
3.2
|
53.1
|
1.0
|
HB2
|
A:CYS319
|
3.3
|
44.4
|
1.0
|
CB
|
A:CYS322
|
3.3
|
47.6
|
1.0
|
HE1
|
A:HIS335
|
3.4
|
48.2
|
1.0
|
HB2
|
A:GLU321
|
3.6
|
63.8
|
1.0
|
N
|
A:CYS322
|
3.7
|
43.8
|
1.0
|
HD3
|
A:LYS338
|
4.0
|
74.5
|
1.0
|
CA
|
A:CYS322
|
4.0
|
46.0
|
1.0
|
HB2
|
A:CYS322
|
4.1
|
57.1
|
1.0
|
CG
|
A:HIS335
|
4.1
|
35.1
|
1.0
|
ND1
|
A:HIS339
|
4.1
|
47.0
|
1.0
|
CG
|
A:HIS339
|
4.2
|
45.6
|
1.0
|
ND1
|
A:HIS335
|
4.2
|
38.4
|
1.0
|
H
|
A:GLU321
|
4.2
|
47.3
|
1.0
|
HB3
|
A:GLN324
|
4.2
|
61.6
|
1.0
|
H
|
A:GLN324
|
4.3
|
52.7
|
1.0
|
CB
|
A:GLU321
|
4.4
|
53.2
|
1.0
|
HB3
|
A:GLU321
|
4.6
|
63.8
|
1.0
|
C
|
A:GLU321
|
4.6
|
46.1
|
1.0
|
HG2
|
A:LYS338
|
4.6
|
69.8
|
1.0
|
H
|
A:GLN323
|
4.6
|
57.1
|
1.0
|
C
|
A:CYS322
|
4.7
|
45.0
|
1.0
|
CA
|
A:CYS319
|
4.7
|
34.7
|
1.0
|
HD23
|
A:LEU336
|
4.8
|
32.8
|
1.0
|
HB2
|
A:GLN324
|
4.8
|
61.6
|
1.0
|
N
|
A:GLU321
|
4.8
|
39.4
|
1.0
|
HA
|
A:CYS322
|
4.8
|
55.2
|
1.0
|
CA
|
A:GLU321
|
4.9
|
46.0
|
1.0
|
HD1
|
A:HIS339
|
4.9
|
56.4
|
1.0
|
N
|
A:GLN323
|
4.9
|
47.6
|
1.0
|
CD
|
A:LYS338
|
4.9
|
62.1
|
1.0
|
CB
|
A:GLN324
|
5.0
|
51.4
|
1.0
|
HD1
|
A:HIS335
|
5.0
|
46.1
|
1.0
|
HA
|
A:CYS319
|
5.0
|
41.6
|
1.0
|
|
Zinc binding site 2 out
of 2 in 6cvr
Go back to
Zinc Binding Sites List in 6cvr
Zinc binding site 2 out
of 2 in the Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Human Aprataxin (Aptx) S242N Bound to Rna-Dna, Amp and Zn Product Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn402
b:59.6
occ:1.00
|
NE2
|
B:HIS335
|
2.1
|
57.8
|
1.0
|
NE2
|
B:HIS339
|
2.2
|
68.0
|
1.0
|
SG
|
B:CYS319
|
2.4
|
45.5
|
1.0
|
SG
|
B:CYS322
|
2.5
|
58.4
|
1.0
|
HB3
|
B:CYS322
|
2.9
|
72.5
|
1.0
|
CE1
|
B:HIS339
|
3.1
|
71.1
|
1.0
|
CE1
|
B:HIS335
|
3.1
|
60.2
|
1.0
|
CD2
|
B:HIS335
|
3.1
|
55.1
|
1.0
|
HB3
|
B:CYS319
|
3.1
|
54.1
|
1.0
|
H
|
B:CYS322
|
3.2
|
76.3
|
1.0
|
CD2
|
B:HIS339
|
3.2
|
65.9
|
1.0
|
HE1
|
B:HIS339
|
3.2
|
85.3
|
1.0
|
CB
|
B:CYS322
|
3.2
|
60.4
|
1.0
|
CB
|
B:CYS319
|
3.2
|
45.0
|
1.0
|
HE1
|
B:HIS335
|
3.3
|
72.3
|
1.0
|
HD2
|
B:HIS335
|
3.3
|
66.2
|
1.0
|
HB2
|
B:CYS319
|
3.3
|
54.1
|
1.0
|
HD2
|
B:HIS339
|
3.4
|
79.0
|
1.0
|
N
|
B:CYS322
|
3.7
|
63.6
|
1.0
|
HB2
|
B:GLU321
|
3.7
|
0.4
|
1.0
|
CA
|
B:CYS322
|
4.0
|
61.5
|
1.0
|
HB2
|
B:CYS322
|
4.0
|
72.5
|
1.0
|
HB3
|
B:GLN324
|
4.1
|
71.2
|
1.0
|
H
|
B:GLU321
|
4.2
|
92.3
|
1.0
|
ND1
|
B:HIS335
|
4.2
|
59.1
|
1.0
|
ND1
|
B:HIS339
|
4.2
|
70.9
|
1.0
|
H
|
B:GLN324
|
4.2
|
66.5
|
1.0
|
HD3
|
B:LYS338
|
4.2
|
98.2
|
1.0
|
CG
|
B:HIS335
|
4.3
|
55.5
|
1.0
|
CG
|
B:HIS339
|
4.3
|
68.0
|
1.0
|
CB
|
B:GLU321
|
4.6
|
88.6
|
1.0
|
C
|
B:GLU321
|
4.6
|
88.8
|
1.0
|
H
|
B:GLN323
|
4.6
|
77.2
|
1.0
|
C
|
B:CYS322
|
4.6
|
61.0
|
1.0
|
CA
|
B:CYS319
|
4.7
|
42.5
|
1.0
|
HG2
|
B:LYS338
|
4.8
|
92.5
|
1.0
|
HA
|
B:CYS322
|
4.8
|
73.8
|
1.0
|
N
|
B:GLU321
|
4.8
|
76.9
|
1.0
|
N
|
B:GLN323
|
4.9
|
64.3
|
1.0
|
HB2
|
B:GLN324
|
4.9
|
71.2
|
1.0
|
CA
|
B:GLU321
|
4.9
|
84.9
|
1.0
|
CB
|
B:GLN324
|
4.9
|
59.3
|
1.0
|
HB3
|
B:GLU321
|
5.0
|
0.4
|
1.0
|
HD1
|
B:HIS339
|
5.0
|
85.0
|
1.0
|
HD1
|
B:HIS335
|
5.0
|
70.9
|
1.0
|
|
Reference:
P.Tumbale,
M.J.Schellenberg,
G.A.Mueller,
E.Fairweather,
M.Watson,
J.N.Little,
J.Krahn,
I.Waddell,
R.E.London,
R.S.Williams.
Mechanism of Aptx Nicked Dna Sensing and Pleiotropic Inactivation in Neurodegenerative Disease. Embo J. V. 37 2018.
ISSN: ESSN 1460-2075
PubMed: 29934293
DOI: 10.15252/EMBJ.201798875
Page generated: Mon Oct 28 19:12:10 2024
|